Cite
HARVARD Citation
Saito, G. et al. (2021). Real-world survey of pneumonitis and its impact on durvalumab consolidation therapy in patients with non-small cell lung cancer who received chemoradiotherapy after durvalumab approval (HOPE-005/CRIMSON). Lung cancer. pp. 86-93. [Online].